Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Pirate Fishing Tycoon Hit with 8.2 Million Euro Fine in Spain

FOR IMMEDIATE RELEASE 18 April 2018 Florindo González Corral, the Spanish fishing tycoon who owned the world’s most infamous pirate fishing vessel, the F/V Thunder, has been fined 8.2 million euros in a civil case brought by the Spanish government. The F/V Thunder was an INTERPOL-wanted fishing vessel that was involved in more than 10 years of illegal fishing in the Southern Ocean before its captain deliberately sank the vessel in the Gulf of Guinea after a 110-day at-sea pursuit by Sea Shepherd vessels. The captain and two of his crew, who were rescued by Sea Shepherd, were

Bona introduces new brush technology that enables exciting wood floor effects

Bona, the leading name in wood floor treatment, introduces a new brush technology that allows professionals to enhance the natural character of wood and create inspirational new looks with ease. With a century-long dedication and passion for wooden floors, Bona has developed an innovative system for creating exciting flooring effects as a part of the Bona Inspiration concept - a floor styling program with inspiration and guidance in flooring trends. New Bona Brush Technology is a unique system that allows the contractor to renovate existing floors to create new, trendy effects,

Fabege AB (publ) executes share split

The Annual General Meeting in Fabege AB (publ) held on 9 April 2018 resolved to increase the total number of shares in the company by dividing each share into two shares (a so called 2:1 share split). The Board of Directors was authorised to decide the record day for the share split.The Board of Directors has resolved that the record day for the share split shall fall on 27 April 2018 and the new shares are expected to be registered in the shareholders’ accounts on 30 April 2018. Last day of trading with shares before the share split is 25 April 2018 and the first day of trading with

Bestic patent granted in China

The State Intellectual Property Office in China informs that they have granted patent for the assistive eating device Bestic®. The patent protects Camanio Care on one of the world’s most essential markets for welfare technology.According to the EU-project ”SILVER” (www.silverpcp.eu), around 0.2% of the adult population is being fed. This is equal to approximately 3 million individuals in China alone. The reasons behind eating difficulties are several. However, neurological diagnosis such as stroke, ALS, Parkinson and spinal cord lesion can cause eating difficulties. People suffering from

NeuroVive’s KL1333 receives FDA Orphan Drug Designation for treatment of mitochondrial diseases

Lund, Sweden, 18 April 2018 NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announced that it has been granted Orphan Drug Designation by the United States FDA Office of Orphan Products Development for its project KL1333 for treatment of inherited mitochondrial respiratory chain diseases (MRCD).Orphan drug designation (ODD) will give the KL1333 program extra access to regulatory and scientific advice and interactions at the FDA and may enable a focused development program and speedy approval process. ODD opens up for market

#18-655 No market making in certain ETPs

Due to technical problems on NASDAQ, issuers are not able to act as market makers in certain instruments. This affects mainly instruments with Nordic underlyings. The instruments concerned will be in an Order Protection Auction thus preventing any trades being executed until the market maker returns with prices. Market making will be resumed as soon as possible. For further information concerning this NGM notice please contact: NGM market surveillance, +46 8 566 390 55, marketsurveillance@ngm.se Nordic Growth Market NGM ABAbout NGM Nordic Growth Market NGM AB (NGM) is an

Preparing for commercialisation of Ygalo®

Stockholm - 18 April 2018 - Oncopeptides AB (Nasdaq Stockholm: ONCO) yesterday announced the notice for the AGM in which the Nomination Committee is proposing two new candidates for the Board of Directors. Per Wold-Olsen and Brian Stuglik will bring additional late-stage development and commercialisation experience to the company should the AGM vote in favour of the proposal. In conjunction with the AGM the proposal is furthermore that Alan Hulme will be stepping down as Chairman after eight successful years and handing over to Per Wold-Olsen as successor. Oncopeptides has over the last

Passenger volumes at Helsinki Airport increasing faster than at other Nordic main airports

In March, the growth of passenger traffic at the main Nordic airports was the fastest at Helsinki Airport for the eleventh consecutive month. The increase in passenger volumes also continues at other Finnish airports. In the first quarter of 2018, Finavia’s airports were visited by a little over 5.9 million passengers.“We carry out a monthly comparison of the growth rate of Helsinki Airport’s international passenger traffic to the reported growth of passenger volumes at other main airports in Northern Europe. In a long-term comparison, we surpassed Oslo in Norway and Copenhagen in Denmark

Concordia Maritime collaborates with the Swedish Institute for the Marine Environment to measure microplastics in the oceans

Together with the Swedish Institute for the Marine Environment, Concordia Maritime has initiated a preliminary study to determine the feasibility of gathering important information on the volume of micoplastics in the oceans. By installing a collection device on a tanker, water samples can be collected while it is under way for subsequent analysis by researchers. The aim is to draw conclusions as to the extent, distribution of microplastics and potential consequences for living organisms.In addition to the Swedish Institute for the Marine Environment, the preliminary study, which is

Change in number of shares in Camanio Care AB (publ)

Conversion of convertible notes into shares under the Convertible Notes issued within the financing agreement announced on December 6th 2017. The date of conversion was April 17th 2018 and the number of Notes converted was 40. The number of Notes remaining under the first Tranche for future conversion is 270. The number of shares and the number of votes before the conversion was 15 918 391. Through the conversion the number of shares and the number of votes has increased by 275 862. The total number of shares and the total number of votes after the conversion amount to 16 194 253.

ChromoGenics notice to Annual General Meeting 2018

Shareholders in ChromoGenics AB (publ) are hereby invited to the Annual General Meeting Wednesday May 16, 2018 at 14.00 CET at the offices of Law firm Lindahl, Vaksalagatan 10, Uppsala.NOTICE OF ANNUAL GENERAL MEETING IN CHROMOGENICS AB (PUBL) The shareholders in ChromoGenics AB (publ) reg. no. 556630-1809 (the “Company”) are hereby convened to the annual general meeting on Wednesday May 16, 2018, at 14.00 at the offices of Law firm Lindahl, Vaksalagatan 10, 751 42 Uppsala. Notice etc. Shareholders who wish to participate at the annual general meeting must: -  on Wednesday May 9,

First clinical study with CS1 completed

Cereno Scientific today announces that the company has completed its clinical study with drug candidate CS1. Preliminary analysis of the study data shows that CS1 was safe and well tolerated.The study was performed in collaboration with Cereno Scientific’s clinical research partner, CTC in Uppsala. In the study, individuals with an increased risk profile for thrombosis participated in evaluating safety, tolerability and pharmacokinetic properties of CS1. Furthermore, effects on risk markers for thrombosis were studied.Cereno continues to analyse all data from the study and hopes to be

Welcome to the Annual General Meeting (AGM) in Opus Group AB (PUBL)

Shareholders of Opus Group AB (publ) are hereby notified of the Annual General Meeting (AGM) to be held on Thursday, May 17, 2018, at 18.00, local time, at the Elite Park Avenue Hotel, Kungsportsavenyen 36, Gothenburg, Sweden. Registration for the AGM takes place from 17:00.NOTICE OF PARTICIPATION Shareholders wishing to participate in the AGM shall be registered in the Shareholders’ Register held by Euroclear Sweden AB as of Friday May 11, 2018, and have notified the company of their intention to attend by Friday May 11, 2018. Notification of participation at the AGM shall be made

Catarina Ihre proposed as a new member of Brighter's Board of Directors.

At Brighter's upcoming annual general shareholders meeting, the Company’s Nomination Committee will propose changes to the Board of Directors, with Catarina Ihre as a new member on the board. Catarina Ihre has worked as an analyst at Deutsche Bank and Nordea and in Investor Relations at Lundin Mining, SSAB and Electrolux. At Electrolux she held the position of VP Investor Relations.  "I look forward to working with Brighter, a visionary company with high ambitions in a very large market. Healthcare must be cheaper, more digital and help patients get higher quality of life. This is what

Notice of Paradox Interactive AB (publ)’s Annual General Meeting 2018

Shareholders in Paradox Interactive AB (publ), 556667-4759 are hereby invited to the Annual General Meeting (AGM) to be held May 18, 2018 13.00 CET at Scandic Malmen, Götgatan 49-51, 116 21 Stockholm.Please note that this is a translation for information purposes only – in case of any discrepancies between this version and the Swedish version, the Swedish version shall prevail. The Annual General Meeting will be held in Swedish only. Notice of attendance Shareholders who wish to attend the AGM shall: ·be entered in the company’s shareholders’ register kept by Euroclear Sweden

Invitation to conference call, April 25 at 2:30 pm CET

Studsvik AB presents its Interim Report for the first quarter 2018 and hereby invites media and analysts to a conference call held in English on Wednesday, April 25 at 2:30 pm CET.Studsvik’s Interim Report for the first quarter 2018 will be distributed at approximately 1.00 pm CET, April 25. As of this time, the report will also be available at www.studsvik.com. The call will be held in English, starting 2:30 pm CET. Please call at least ten minutes prior to the start of the conference call to avoid delay. Event title is: Studsvik Q1 2018. Conference ID is: 6783509  Description

Interim Report January-March 2018

First quarter 2018 compared to first quarter 2017 · Customer growth was 42,400 (38,400), which marked the second largest increase ever for a single quarter · Net inflow in the quarter was SEK 7,960 million, a decrease of 8 per cent · Operating income increased by 11 per cent, mainly due to higher fund volymes and, as a result, higher fund commissions. Other income also increased, mainly as a result of increased trading in foreign securities and higher income from Avanza Markets · Operating expenses increased by 23 per cent, mainly due to expanded development capacity for

Notice of annual general meeting in Scandi Standard AB (publ)

Scandi Standard AB (publ), 556921-0627, holds its annual general meeting on Tuesday 22 May 2018 at 1.00 p.m. CET at IVA Konferenscenter, Grev Turegatan 16 in Stockholm. The entrance to the meeting will open at noon CET. RIGHT TO PARTICIPATE AND NOTICE OF ATTENDANCE Those who wish to attend the annual general meeting must: · be entered as a shareholder in the share register kept by Euroclear Sweden AB on Wednesday 16 May 2018; and · give notice of attendance to the company no later than on Wednesday 16 May 2018. Notice of attendance may be given by telephone +46 (0)8 402 90

Official notification of the annual general meeting.

Brighter AB (publ) will hold its Annual General Meeting (AGM) on Wednesday 16th of May 2018, at 11:00, at the offices of Brighter AB, Norgegatan 2 in Kista, Sweden. RIGHT TO PARTICIPATE AND REGISTRATION Those who wish to participate in the Meeting must: ●   Be registered as a shareholder in the shareholder register maintained by Euroclear Sweden AB by Wednesday 9th of May 2018 and,  ●   Inform the company of their intent to participate in the Meeting by Thursday 10th of May 2018 at the latest.  Registration of participation must be made in writing to – preferably – ir@brighter.

BerGenBio: Promising data highlighting selective AXL inhibitor bemcentinib’s potential to improve efficacy of checkpoint inhibitors presented at AACR

Bergen, Norway, 18 April 2018 – BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for multiple cancer indications, announces that promising preclinical data with its lead AXL inhibitor bemcentinib (formerly BGB324) has been presented in a poster at the 2018 American Association for Cancer Research (AACR) Annual Meeting on 14-18 April in Chicago, IL, USA.The data highlight bemcentinib’s potential to reverse tumour immune suppression and enhance immune checkpoint inhibitor efficacy. The authors show that bemcentinib

Mycronic launches a new mask writer for the multi-purpose market

Täby, 18 April, 2018 – Mycronic AB (publ) launches the new FPS8100 to meet the increasing demand on photomasks for fine metal mask manufacturing, which are used in the deposition process of the organic material when producing OLED displays. Mycronic offers mask writers for the manufacturing of photomasks within different fields of application. These areas are display manufacturing (for TV, smart phones and tablets among other things) and applications within the multi-purpose market, a broad segment comprising many different application areas. The FPS8100 can be used for a wide range

Invitation to the presentation of Resurs’s first quarter report 2018

Resurs’s report for the first quarter 2018 will be published at 07:30 CET on April 25th. A web-cast telephone conference will be held at 09:00 CET the same day, where Resurs’s CEO Kenneth Nilsson and CFO Peter Rosén will present the report. The presentation will be followed by a Q&A session.The presentation will be held in Swedish and can be followed on the web or over the phone. The presentation will also be translated into English and can be followed on the web or over the phone. To participate in the conference call, call one of the following numbers: Sweden +46850336563UK

Siemens and Hendrick Motorsports extend championship-winning technical partnership

· Hendrick Motorsports leverages Siemens’ digital twin technology for racing success · Siemens’ NX, Simcenter and Teamcenter software enable improved response times to create competitive advantages on the racetrackAnnounced today, Siemens PLM Software and 12-time NASCAR Cup Series champions Hendrick Motorsports have extended their longstanding technical partnership through the 2024 racing season. One of NASCAR’s most successful teams with a record 15 national series owner’s titles, Hendrick Motorsports began using software in its engine engineering department in the early 1990s and has

There are no items matching the current filter
There are no more items matching the current filter
Back to top